Products for Research Use Only
RegisterLogin

(E, E) -RGFP966

CAT: 0804-HY-W019710-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W019710-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(E, E) -RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s disease[1].
CAS Number
1396841-57-8
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/e-e-rgfp966.html
Purity
99.31
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(F)C=C1N)/C=C/C2=CN(C/C=C/C3=CC=CC=C3)N=C2
Molecular Formula
C21H19FN4O
Molecular Weight
362.40
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P501
References & Citations
[1]Jia H, et al. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice. PLoS One. 2016 Mar 31;11 (3) :e0152498.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-13909-01RGFP966
HY-128978(E, E) -RAMB4
HY-Y0248-01(E, ​E) ​-​Farnesol
HY-114770(E, E) -GLL398
HY-N0007-01(E, E) -Bisdemethoxycurcumin
HY-131520(E, E, E) -Farnesyl alcohol azide
HY-N12873(E, E, E, ) -10,12,14-Hexadecatrienal
HY-P10922Cathepsin E substrate e
HY-Y0248R-01(E, E) -Farnesol (Standard)
HY-W749519(E, E) -Farnesol-13C3

Alternative Products

CatalogName
A8803-200RGFP966

Popular Products